These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3840779

  • 1. Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether.
    Sánchez-Crespo M, Fernández-Gallardo S, Nieto ML, Baranès J, Braquet P.
    Immunopharmacology; 1985 Oct; 10(2):69-75. PubMed ID: 3840779
    [Abstract] [Full Text] [Related]

  • 2. Evidence of a role for PAF-acether in the pathophysiology of the shock state.
    Sanchez Crespo M, Inarrea P, Nieto ML, Fernandez-Gallardo S.
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():181-96. PubMed ID: 3774844
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of paf-acether in the mediation of pathophysiological responses to aggregated immunoglobulins. Studies with the platelet-activating factor receptor antagonist BN 52021.
    Fernandez-Gallardo S, Cano E, Braquet P, Sanchez Crespo M.
    Int J Immunopharmacol; 1988 Aug; 10(4):353-60. PubMed ID: 3139574
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
    Nunez D, Chignard M, Korth R, Le Couedic JP, Norel X, Spinnewyn B, Braquet P, Benveniste J.
    Eur J Pharmacol; 1986 Apr 16; 123(2):197-205. PubMed ID: 3086108
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021.
    Braquet P, Guinot P, Touvay C.
    Agents Actions Suppl; 1987 Apr 16; 21():97-117. PubMed ID: 3314418
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
    Etienne A, Hecquet F, Guilmard C, Soulard C, Braquet P.
    Int J Tissue React; 1987 Apr 16; 9(1):19-26. PubMed ID: 3596954
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
    Lachachi H, Plantavid M, Simon MF, Chap H, Braquet P, Douste-Blazy L.
    Biochem Biophys Res Commun; 1985 Oct 30; 132(2):460-6. PubMed ID: 2998370
    [Abstract] [Full Text] [Related]

  • 19. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
    Braquet P.
    Adv Prostaglandin Thromboxane Leukot Res; 1986 Oct 30; 16():179-98. PubMed ID: 2949548
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.